These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 31732854)
1. Effect of palonosetron and dexamethasone administration on the prevention of gastrointestinal symptoms in hepatic arterial chemoembolization with epirubicin. Sakamoto T; Saito Y; Kobayashi M; Yamada T; Takekuma Y; Nakai M; Ogawa K; Iseki K; Sugawara M Support Care Cancer; 2020 Jul; 28(7):3251-3257. PubMed ID: 31732854 [TBL] [Abstract][Full Text] [Related]
2. Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride. Sohara N; Takagi H; Abe T; Hashimoto Y; Kojima A; Takahashi H; Nagamine T; Mori M Support Care Cancer; 1999 Mar; 7(2):84-8. PubMed ID: 10089088 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety analysis of dexamethasone + palonosetron in prevention of post-embolization syndrome after D-TACE: A retrospective study. Lu H; Zheng C; Liang B; Xia X Medicine (Baltimore); 2023 Oct; 102(40):e35433. PubMed ID: 37800841 [TBL] [Abstract][Full Text] [Related]
4. Dexamethasone Prophylaxis to Alleviate Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Study. Yang H; Seon J; Sung PS; Oh JS; Lee HL; Jang B; Chun HJ; Jang JW; Bae SH; Choi JY; Yoon SK J Vasc Interv Radiol; 2017 Nov; 28(11):1503-1511.e2. PubMed ID: 28941589 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131). Nishio S; Aihara S; Shimokawa M; Fujishita A; Taniguchi S; Hachisuga T; Yanazume S; Kobayashi H; Murakami F; Numa F; Kotera K; Okura N; Toki N; Yokoyama M; Ushijima K J Gynecol Oncol; 2018 Sep; 29(5):e77. PubMed ID: 30022637 [TBL] [Abstract][Full Text] [Related]
6. [Impact of preventive administration of antiemetic drugs on risk of acute nausea and vomiting induced by transcatheter arterial chemoembolization in patients with hepatocellular carcinomas - a retrospective study]. Kabuki M; Higashihara H; Kakuda M; Fujita Y; Masuda J; Kin K; Ueguchi T; Osuga K; Tomiyama N Gan To Kagaku Ryoho; 2013 Feb; 40(2):197-201. PubMed ID: 23411955 [TBL] [Abstract][Full Text] [Related]
7. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results. Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093 [TBL] [Abstract][Full Text] [Related]
9. Postembolization syndrome after hepatic transarterial chemoembolization: effect of prophylactic steroids on postprocedure medication requirements. Kogut MJ; Chewning RH; Harris WP; Hippe DS; Padia SA J Vasc Interv Radiol; 2013 Mar; 24(3):326-31. PubMed ID: 23380736 [TBL] [Abstract][Full Text] [Related]
10. Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer. Wu F; Lin X; Yang Z; Sun Z; Zeng F; Heng J; Qu J; Zeng L; Yang N; Zhang Y Clin Lung Cancer; 2018 Nov; 19(6):e913-e918. PubMed ID: 30197265 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the Efficacy and Safety of Palonosetron Hydrochloride in Preventing Nausea And Vomiting After TACE: A Retrospective Analysis. Lu H; Zheng C; Liang B; Xia X Curr Radiopharm; 2024; 17(1):46-54. PubMed ID: 38037910 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization. He JJ; Yin XX; Wang T; Chen MY; Li XL; Yang XJ; Shao HY J Cancer Res Ther; 2021 Jul; 17(3):777-783. PubMed ID: 34269313 [TBL] [Abstract][Full Text] [Related]
13. [Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: a randomized, controlled and double-blinded prospective trial]. Feng YL; Ling CQ; Zhu DZ; Yu CQ; Chen Z; Li B Zhong Xi Yi Jie He Xue Bao; 2005 Mar; 3(2):99-102. PubMed ID: 15763053 [TBL] [Abstract][Full Text] [Related]
14. Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma. Shirono T; Iwamoto H; Niizeki T; Shimose S; Nakano M; Satani M; Okamura S; Noda Y; Kamachi N; Kuromatsu R; Sakai M; Nomiyama M; Kuwano T; Tanaka M; Koga H; Torimura T Oncology; 2019; 96(2):79-86. PubMed ID: 30293080 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer. Kusagaya H; Inui N; Karayama M; Fujisawa T; Enomoto N; Kuroishi S; Nakamura Y; Matsuda H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Yamada T; Shirai T; Hayakawa H; Suda T Lung Cancer; 2015 Dec; 90(3):410-6. PubMed ID: 26791800 [TBL] [Abstract][Full Text] [Related]
16. Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy. Aapro M; Fabi A; Nolè F; Medici M; Steger G; Bachmann C; Roncoroni S; Roila F Ann Oncol; 2010 May; 21(5):1083-8. PubMed ID: 20080830 [TBL] [Abstract][Full Text] [Related]
17. Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards. Lucatelli P; Argirò R; De Rubeis G; Rocco B; Corradini SG; Corona M; Nardis PG; Saba L; Mennini G; Fiorentino F; Corsi A; Catalano C; Bezzi M J Vasc Interv Radiol; 2019 Mar; 30(3):305-313. PubMed ID: 30713031 [TBL] [Abstract][Full Text] [Related]
18. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. Saito M; Aogi K; Sekine I; Yoshizawa H; Yanagita Y; Sakai H; Inoue K; Kitagawa C; Ogura T; Mitsuhashi S Lancet Oncol; 2009 Feb; 10(2):115-24. PubMed ID: 19135415 [TBL] [Abstract][Full Text] [Related]
19. Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience. Seki A; Hori S; Kobayashi K; Narumiya S Cardiovasc Intervent Radiol; 2011 Jun; 34(3):557-65. PubMed ID: 20821211 [TBL] [Abstract][Full Text] [Related]
20. Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma. Furuse J; Ishii H; Satake M; Onaya H; Nose H; Mikami S; Sakai H; Mera K; Maru Y; Yoshino M Am J Clin Oncol; 2003 Apr; 26(2):159-64. PubMed ID: 12714888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]